Pluri Inc. financial data

Symbol
PLUR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Matam Advanced Technology Park, Building No. 5, Haifa, Israel
State of incorporation
Nevada
Fiscal year end
June 30
Former names
PLURISTEM THERAPEUTICS INC (to 7/13/2022), PLURISTEM LIFE SYSTEMS INC (to 12/28/2007), AI SOFTWARE INC (to 7/1/2003)
Latest financial report
10-Q - Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 717 % -21%
Return On Equity -248 % -111%
Return On Assets -49.9 % +1.4%
Operating Margin -6.65K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.39M shares -86.9%
Common Stock, Shares, Outstanding 5.23M shares -87.3%
Entity Public Float 34.4M USD -23.3%
Weighted Average Number of Shares Outstanding, Basic 5.22M shares +4.56%
Weighted Average Number of Shares Outstanding, Diluted 5.22M shares +4.56%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 341K USD -18.4%
Research and Development Expense 14.4M USD -19.5%
General and Administrative Expense 10.4M USD -14.4%
Operating Income (Loss) -22.7M USD +23.4%
Nonoperating Income (Expense) 580K USD
Net Income (Loss) Attributable to Parent -21.6M USD +30%
Earnings Per Share, Basic -0.08 USD/shares +96.4%
Earnings Per Share, Diluted -0.08 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.08M USD +92.6%
Cash, Cash Equivalents, and Short-term Investments 26.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3K USD -84.2%
Assets, Current 27.4M USD -41.4%
Property, Plant and Equipment, Net 769K USD +12.9%
Operating Lease, Right-of-Use Asset 7.15M USD -8.33%
Other Assets, Noncurrent 7K USD +250%
Assets 36.4M USD -35.3%
Employee-related Liabilities, Current 508K USD -18.6%
Accrued Liabilities, Current 958K USD -28.2%
Liabilities, Current 4.53M USD -15.8%
Operating Lease, Liability, Noncurrent 5.34M USD -11.3%
Retained Earnings (Accumulated Deficit) -415M USD -5.5%
Stockholders' Equity Attributable to Parent -356K USD -102%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.85M USD -91.2%
Liabilities and Equity 36.4M USD -35.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.86M USD +23%
Net Cash Provided by (Used in) Investing Activities 5.8M USD -9.24%
Common Stock, Shares Authorized 37.5M shares -37.5%
Common Stock, Shares, Issued 5.23M shares -87.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -97K USD +93%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.99M USD +74.4%
Deferred Tax Assets, Valuation Allowance 84.9M USD +19.1%
Deferred Tax Assets, Gross 71.3M USD +11.5%
Operating Lease, Liability 6.38M USD -10.5%
Depreciation 67K USD -33%
Payments to Acquire Property, Plant, and Equipment 103K USD +41.1%
Lessee, Operating Lease, Liability, to be Paid 8.97M USD
Property, Plant and Equipment, Gross 18.1M USD +1.75%
Operating Lease, Liability, Current 675K USD +7.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.12M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.02M USD
Deferred Tax Assets, Operating Loss Carryforwards 80.5M USD +23.2%
Preferred Stock, Shares Authorized 1M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 993K USD
Additional Paid in Capital 414M USD +0.53%
Deferred Tax Assets, Net of Valuation Allowance 84.9M USD +19.1%
Share-based Payment Arrangement, Expense 43K USD -23.2%
Interest Expense 868K USD +0.46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares